The effect of asthma pre-treatment on the efficacy of flutiform® treatment with respect to asthma control in patients with asthma in daily clinical practice; an epidemiologic study. (FLT9502)

Study identification

• EU PAS number:
  EUPAS3889
• Study ID:
  15240
• Official title and acronym:
  The effect of asthma pre-treatment on the efficacy of flutiform® treatment with respect to asthma control in patients with asthma in daily clinical practice; an epidemiologic study. (FLT9502)
• DARWIN EU® study:
  No
• Study countries:
  Netherlands
• Study description:
  To evaluate the effect of asthma pre-treatment on the efficacy of flutiform® treatment with respect to asthma control in patients with asthma in daily clinical practice.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Mundipharma

Study timelines

Date when funding contract was signed

Planned:07/01/2013

Actual:07/01/2013

Study start date

Planned:07/01/2013

Actual:07/01/2013

Data analysis start date

Planned:01/05/2014

Actual:01/05/2014

Date of final study report

Planned:07/01/2014

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Mundipharma Pharmaceuticals BV

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable